Compounds > 5-(tetradecyloxy)-2-furancarboxylic acid
Page last updated: 2024-09-03

5-(tetradecyloxy)-2-furancarboxylic acid and pimozide

5-(tetradecyloxy)-2-furancarboxylic acid has been researched along with pimozide in 1 studies

Compound Research Comparison

Studies
(5-(tetradecyloxy)-2-furancarboxylic acid)		Trials
(5-(tetradecyloxy)-2-furancarboxylic acid)		Recent Studies (post-2010)
(5-(tetradecyloxy)-2-furancarboxylic acid)		Studies
(pimozide)		Trials
(pimozide)		Recent Studies (post-2010) (pimozide)
510161,837143152

Protein Interaction Comparison

ProteinTaxonomy5-(tetradecyloxy)-2-furancarboxylic acid (IC50)pimozide (IC50)
XBP1Homo sapiens (human)10
Voltage-dependent L-type calcium channel subunit alpha-1FHomo sapiens (human)0.201
Ubiquitin carboxyl-terminal hydrolase 1Homo sapiens (human)2
Potassium channel subfamily K member 2Homo sapiens (human)1.8
Bile salt export pumpHomo sapiens (human)10
Sodium channel protein type 2 subunit alphaRattus norvegicus (Norway rat)0.34
ATP-dependent translocase ABCB1Homo sapiens (human)2.2
Cytochrome P450 3A4Homo sapiens (human)9.7
DRattus norvegicus (Norway rat)0.0004
D(3) dopamine receptorRattus norvegicus (Norway rat)0.0004
ATP-dependent translocase ABCB1Mus musculus (house mouse)4.9
D(1B) dopamine receptorRattus norvegicus (Norway rat)0.0004
D(4) dopamine receptorRattus norvegicus (Norway rat)0.0004
Mu-type opioid receptorHomo sapiens (human)0.372
Sodium channel protein type 1 subunit alphaHomo sapiens (human)0.054
Sodium channel protein type 4 subunit alphaHomo sapiens (human)0.054
Delta-type opioid receptorHomo sapiens (human)3.76
Kappa-type opioid receptorHomo sapiens (human)0.99
D(2) dopamine receptorRattus norvegicus (Norway rat)0.0004
Sodium channel protein type 7 subunit alphaHomo sapiens (human)0.054
Voltage-dependent L-type calcium channel subunit alpha-1D Homo sapiens (human)0.201
Potassium voltage-gated channel subfamily H member 2Homo sapiens (human)0.152
Voltage-dependent L-type calcium channel subunit alpha-1SHomo sapiens (human)0.201
Voltage-dependent L-type calcium channel subunit alpha-1CHomo sapiens (human)0.201
Sodium channel protein type 5 subunit alphaHomo sapiens (human)0.054
Sodium channel protein type 9 subunit alphaHomo sapiens (human)0.054
WD repeat-containing protein 48Homo sapiens (human)2
Sodium channel protein type 2 subunit alphaHomo sapiens (human)0.054
Sodium channel protein type 3 subunit alphaHomo sapiens (human)0.054
Sodium channel protein type 11 subunit alphaHomo sapiens (human)0.054
Sodium channel protein type 8 subunit alphaHomo sapiens (human)0.054
Sodium channel protein type 10 subunit alphaHomo sapiens (human)0.054

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Berre, S; Bracher, F; Braun, P; Couderc, T; Gangneux, N; Karlas, A; Karo-Astover, L; Klemm, U; Lecuit, M; Merits, A; Meyer, M; Meyer, TF; Raftery, M; Schönrich, G; Varjak, M; Weege, F; Wurzlbauer, A1

Other Studies

1 other study(ies) available for 5-(tetradecyloxy)-2-furancarboxylic acid and pimozide

ArticleYear
A human genome-wide loss-of-function screen identifies effective chikungunya antiviral drugs.
    Nature communications, 2016, 05-12, Volume: 7

    Topics: Animals; Antiviral Agents; Chikungunya Fever; Chikungunya virus; Furans; Gene Expression Profiling; Genome, Human; HEK293 Cells; Host-Pathogen Interactions; Humans; Mice; Pimozide; RNA, Small Interfering; Small Molecule Libraries; Virus Replication

2016